# Carnitine Infusion and Insulin Resistance

> **NCT02722902** · NA · TERMINATED · sponsor: **Maastricht University Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Glucose Intolerance

## Interventions

- **DRUG:** Carnitor
- **DIETARY_SUPPLEMENT:** IntraLipid
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02722902
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** No effect of carnitine on lipid induced insulin resistance after n=8 (p=1.00)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722902, "Carnitine Infusion and Insulin Resistance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02722902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*